Axe Compute Inc. is focused on artificial intelligence (AI) compute accessible to all through its access to the Aethir network. By delivering Aethir-provided decentralized global infrastructure, the Company will endeavor to deliver instant access to bare-metal GPUs at scale to innovators and established businesses alike. Dedicated GPU clusters delivered in 48 hours across 200+ locations. It offers Zero Virtualization Overhead, Purpose-Built for AI Workloads, Flat Rate, Zero Egress Fees, and Enterprise-Grade Support and SLAs. It provides 100% bare-metal access.

Employees

Sector

Biotechnology & Medical Research

More about the company

Market Cap	72.94M 64.08M 59.41M 54.64M 103M 6.97B 105M 708M 277M 3.43B 274M 268M 11.85B	P/E 2024	-0.35x	P/E 2025	-0.53x
Enterprise Value	63.81M 56.06M 51.98M 47.8M 90.31M 6.1B 92.25M 620M 243M 3B 240M 234M 10.36B	EV / Sales 2024	4.23x	EV / Sales 2025	121x
Free-Float	93.75%	Yield 2024 *	-	Yield 2025	-

06-29	Axe Compute Inc.(NasdaqCM:AGPU) added to Russell Microcap Value Benchmark Index	CI
06-29	Axe Compute Inc.(NasdaqCM:AGPU) added to Russell 3000E Index	CI
06-28	Axe Compute Inc.(NasdaqCM:AGPU) added to Russell 3000E Value Benchmark	CI
06-28	Axe Compute Inc.(NasdaqCM:AGPU) added to Russell Microcap Index	CI
06-16	Axe Compute Inc. Secures $25.9 Million in Contracts for Long-Term Deployments of Blackwell and Grace Blackwell Compute	CI
06-09	Axe Compute Files $1 Billion Mixed Shelf	MT
05-27	Axe Compute Inc. Receives $43 Million Payment for Landmark Contract	CI
05-18	Axe Compute Inc., Q1 2026 Earnings Call, May 18, 2026
05-15	Axe Compute Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
04-22	Top Midday Gainers	MT
04-22	Axe Compute Receives $260 Million Contract to Provide Nvidia B300 Chips; Shares Jump Pre-Bell	MT
04-22	Axe Compute Inc Secures $260 Million Three-Year Enterprise Contract for 2,304-GPU NVIDIA B300 Deployment	CI
04-20	Axe Compute Inc Announces Strategic Compute Reserve Dashboard Launch	CI

15/11/24	HC Wainwright Downgrades Predictive Oncology to Neutral From Buy	MT
30/06/21	PREDICTIVE ONCOLOGY : HC Wainwright Starts Predictive Oncology at Buy With $5 Price Target	MT

07-07	Axe Compute Inc. Joins Russell Microcap® Index, Reflecting Its Growth as a Publicly Traded AI Infrastructure Platform	AQ
06-16	Axe Compute Secures $25.9 Million in Contracts for Long-Term Deployments of Blackwell and Grace Blackwell Compute	AQ
05-27	Axe Compute Receives $43M Payment for Landmark Contract	AQ
05-15	Axe Compute Inc. Reports First Quarter 2026 Financial Results and Provides Business Update	AQ
05-11	Axe Compute to Host Q1 2026 Financial Results Conference Call	AQ

16/03/21	MÄRKTE USA/Wall Street mit Fed-Sitzung in Lauerstellung
16/03/21	New Fortress Energy : MÄRKTE USA/Wall Street mit Fed-Sitzung uneinheitlich
16/03/21	New Fortress Energy : MÄRKTE USA/S&P-500 mit Rekordhoch trotz enttäuschender US-Daten
16/03/21	New Fortress Energy : MÄRKTE USA/Wenig verändert - US-Daten liefern gemischtes Bild
16/03/21	New Fortress Energy : MARKT USA/Wenig verändert - US-Daten könnten Impulse liefern

Precision Therapeutics Inc Share Price Nasdaq

Stocks

US74033P1003

Biotechnology & Medical Research

Valuation: Precision Therapeutics Inc

Latest news : Precision Therapeutics Inc

Last Transcript: Precision Therapeutics Inc

Analysts' recommendations: Precision Therapeutics Inc

Press Releases: Precision Therapeutics Inc

News in other languages: Precision Therapeutics Inc

Quotes and Performance

Managers and Directors: Precision Therapeutics Inc

Other Biotechnology & Medical Research

Financials

Company Profile

Manager	Title	Age	Since
Christopher Miglino CEO	Chief Executive Officer	57	08/02/2026
Jeremy Yaukey-Witter DFI	Director of Finance/CFO	-	15/04/2026
Kyle Okamoto PSD	President	-	31/03/2026

Director	Title	Age	Since
Daniel Handley BRD	Director/Board Member	66	18/02/2020
Charles L. Nuzum CHM	Chairman	78	08/02/2026
Gregory St. Clair BRD	Director/Board Member	60	08/07/2020

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
PRECISION THERAPEUTICS INC	-7.56%	-8.33%	-	-	76.58M
LONZA GROUP AG	+0.44%	+2.51%	+4.36%	+10.27%	50.73B
REVOLUTION MEDICINES, INC.	-1.57%	-2.80%	+383.82%	+582.81%	39.73B
IQVIA HOLDINGS INC.	-0.14%	+0.25%	+27.49%	-5.23%	34.69B
BEONE MEDICINES AG	+1.76%	+2.12%	+21.44%	+58.27%	33.21B
CELLTRION, INC.	-0.06%	-4.63%	+2.94%	+31.65%	26.76B
ASCENDIS PHARMA A/S	-1.93%	-3.38%	-	-	16.8B
MEDPACE HOLDINGS, INC.	-1.49%	-4.92%	+63.89%	+119.25%	15.37B
EUROFINS SCIENTIFIC SE	+0.78%	+0.20%	+14.69%	+17.08%	13.78B
ICON PUBLIC LIMITED COMPANY	-0.97%	-4.02%	+10.35%	-31.69%	12.85B
Average	-0.88%	-0.98%	+66.12%	+97.80%	27.1B
Weighted average by Cap.	+0.13%	-0.38%	+81.60%	+123.01%

	2024	2025
Net sales	1.62M 1.43M 1.32M 1.22M 2.3M 155M 2.35M 15.77M 6.18M 76.3M 6.1M 5.96M 264M	125K 110K 102K 93.85K 177K 11.98M 181K 1.22M 476K 5.89M 470K 460K 20.35M
Net income	-12.66M -11.13M -10.32M -9.49M -17.92M -1.21B -18.31M -123M -48.16M -595M -47.55M -46.51M -2.06B	-233M -205M -190M -175M -330M -22.29B -337M -2.26B -886M -10.95B -875M -856M -37.86B
Net Debt	1.4M 1.23M 1.14M 1.05M 1.98M 134M 2.02M 13.56M 5.31M 65.61M 5.24M 5.13M 227M	-9.12M -8.02M -7.43M -6.84M -12.91M -873M -13.19M -88.62M -34.7M -429M -34.26M -33.51M -1.48B